Evoke System | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

46,564 results for “Evoke System”

Trials

View all 35364 →

Treatment With the Evoke System for Facial and Submental Laxity

85 participants · First posted Jan 22, 2021

Not yet recruiting

EVA: Evaluation of EVOKE Therapy Metrics Generated Using the Evoke System With EVA

40 participants · First posted Dec 5, 2025

APM in the Evoke SCS System to Program Patients With Chronic Pain of the Trunk and/or Limbs

30 participants · First posted Sep 28, 2023

Drugs

View all 835 →

C213 Microneedle System

drug delivery system

OLipHEX delivery system

Organizations

View all 414 →

Evoke Pharma, Inc.

United States

Ryder System

United States

LEGACY HEALTH SYSTEM

United States

News

View all 9951 →

Saluda Medical Launches EVA Sensing Technology for Personalized Spinal Cord Stimulation in U.S.

Saluda Medical's EVA Platform Receives FDA Approval for Automated Spinal Cord Stimulation Programming

Firefly Neuroscience and Next Health Launch Precision Cognitive Health Platform Following FDA Advisory Committee Recommendation on Neuroprotective Peptides

Page 1 of 4657